COVID-19 Daily Update 4-11-2021 – West Virginia Department of Health and Human Resources

The West
Virginia Department of Health and Human Resources
(DHHR) reports as of April 11, 2021, there have been
2,548,540 total
confirmatory laboratory results received for COVID-19, with 146,169 total cases
and 2,745 total
deaths.

 

DHHR has
confirmed the deaths of
a
79-year old male from Greenbrier County, a 70-year old female from Raleigh
County, and a 95-year old female from Lincoln County.

“As our country and parts of our state are
seeing an increase in COVID-19 cases, please continue all prevention measures
to keep your family and neighbors protected,” said Bill J. Crouch, DHHR Cabinet
Secretary. “We offer our deepest sympathies to these families.”

CASES PER COUNTY: Barbour
(1,330), Berkeley (11,261), Boone (1,836), Braxton (852), Brooke (2,087),
Cabell (8,535), Calhoun (262), Clay (430), Doddridge (534), Fayette (3,179),
Gilmer (733), Grant (1,223), Greenbrier (2,564), Hampshire (1,665), Hancock
(2,674), Hardy (1,422), Harrison (5,305), Jackson (1,866), Jefferson (4,226),
Kanawha (13,700), Lewis (1,123), Lincoln (1,378), Logan (2,982), Marion
(4,054), Marshall (3,236), Mason (1,915), McDowell (1,453), Mercer (4,488),
Mineral (2,714), Mingo (2,372), Monongalia (8,865), Monroe (1,044), Morgan
(1,051), Nicholas (1,439), Ohio (3,972), Pendleton (676), Pleasants (827),
Pocahontas (627), Preston (2,781), Putnam (4,710), Raleigh (5,935), Randolph
(2,477), Ritchie (650), Roane (566), Summers (742), Taylor (1,179), Tucker (522),
Tyler (669), Upshur (1,808), Wayne (2,791), Webster (453), Wetzel (1,204), Wirt
(372), Wood (7,536), Wyoming (1,874).

Delays may
be experienced with the reporting of information from the local health
department to DHHR. As case surveillance continues at the local health
department level, it may reveal that those tested in a certain county may not
be a resident of that county, or even the state as an individual in question
may have crossed the state border to be tested
.

West Virginians may pre-register
for their COVID-19 vaccination at
vaccinate.wv.gov. The
COVID-19 dashboard located at
www.coronavirus.wv.gov shows
the total number of vaccines administered. Please see the vaccine summary tab
for more detailed information.

 

Free COVID-19 testing is available today
in Boone, Calhoun, and Raleigh counties:

Boone County

1:00 PM– 4:00 PM, Boone County Health
Department, 213 Kenmore Dr, Danville, WV
(pre-registration:
https://wv.getmycovidresult.com/)

Calhoun County

11:00 AM – 5:00 PM, Stump Funeral Home,
1440 Arnoldsburg Road, Arnoldsburg, WV

Raleigh County

1:00 PM – 4:00 PM, Beckley-Raleigh County
Health Department, 1602 Harper Road, Beckley WV
(pre-registration:
https://wv.getmycovidresult.com/)

 

For
further testing, as well as pharmacy testing, visit
https://dhhr.wv.gov/COVID-19/pages/testing.aspx.

 

Coronavirus (COVID-19) Update: April 9, 2021 – FDA.gov

For Immediate Release:

The U.S. Food and Drug Administration (FDA), today, announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:

  • The FDA issued a letter to health care personnel and facilities recommending transition from use of decontaminated disposable respirators. The FDA is recommending health care personnel and facilities transition away from crisis capacity conservation strategies, such as decontaminating or bioburden reducing disposable respirators for reuse. Based on the increased domestic supply of new respirators approved by the Centers for Disease Control and Prevention’s (CDC) National Institute for Occupational Safety and Health (NIOSH) currently available to facilitate this transition, the FDA and CDC believe there is adequate supply of respirators to transition away from use of decontamination and bioburden reduction systems.
  • As part of the FDA’s effort to protect consumers and animals, the agency issued warning letters jointly with the Federal Trade Commission (FTC) to two companies for selling unapproved products with fraudulent COVID-19 claims. The FDA requested the companies take immediate action to cease the sale of any unapproved and unauthorized products for the treatment or prevention of COVID-19. Consumers concerned about COVID-19 should consult with their health care provider.
    • The first company, Allure Imports, sells products, including “Silver Soul Immune Support”, “Silver Soul Body Spray” and “Vitality C60,” and misleadingly represents that the products can mitigate, prevent, treat, diagnose or cure COVID-19 in people and animals.
    • The second company, About Mineral, sells “Puriton” topical skin products, and misleadingly represents that the products can mitigate, prevent, treat, diagnose or cure COVID-19 in people.
  • Testing updates:
    • As of today, 354 tests and sample collection devices are authorized by the FDA under emergency use authorizations (EUAs). These include 258 molecular tests and sample collection devices, 75 antibody and other immune response tests, and 21 antigen tests. There are 43 molecular authorizations and 1 antibody authorization that can be used with home-collected samples. There is one molecular prescription at-home test, two antigen prescription at-home test, four over-the-counter (OTC) at-home antigen test, and one OTC molecular test.
    • The FDA has authorized 6 antigen tests and 1 molecular test for serial screening programs.

Related Information

###

Boilerplate

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.


Inquiries

Consumer:
888-INFO-FDA

Coronavirus (COVID-19) Update: April 9, 2021 – FDA.gov – FDA.gov

For Immediate Release:

The U.S. Food and Drug Administration (FDA), today, announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:

  • The FDA issued a letter to health care personnel and facilities recommending transition from use of decontaminated disposable respirators. The FDA is recommending health care personnel and facilities transition away from crisis capacity conservation strategies, such as decontaminating or bioburden reducing disposable respirators for reuse. Based on the increased domestic supply of new respirators approved by the Centers for Disease Control and Prevention’s (CDC) National Institute for Occupational Safety and Health (NIOSH) currently available to facilitate this transition, the FDA and CDC believe there is adequate supply of respirators to transition away from use of decontamination and bioburden reduction systems.
  • As part of the FDA’s effort to protect consumers and animals, the agency issued warning letters jointly with the Federal Trade Commission (FTC) to two companies for selling unapproved products with fraudulent COVID-19 claims. The FDA requested the companies take immediate action to cease the sale of any unapproved and unauthorized products for the treatment or prevention of COVID-19. Consumers concerned about COVID-19 should consult with their health care provider.
    • The first company, Allure Imports, sells products, including “Silver Soul Immune Support”, “Silver Soul Body Spray” and “Vitality C60,” and misleadingly represents that the products can mitigate, prevent, treat, diagnose or cure COVID-19 in people and animals.
    • The second company, About Mineral, sells “Puriton” topical skin products, and misleadingly represents that the products can mitigate, prevent, treat, diagnose or cure COVID-19 in people.
  • Testing updates:
    • As of today, 354 tests and sample collection devices are authorized by the FDA under emergency use authorizations (EUAs). These include 258 molecular tests and sample collection devices, 75 antibody and other immune response tests, and 21 antigen tests. There are 43 molecular authorizations and 1 antibody authorization that can be used with home-collected samples. There is one molecular prescription at-home test, two antigen prescription at-home test, four over-the-counter (OTC) at-home antigen test, and one OTC molecular test.
    • The FDA has authorized 6 antigen tests and 1 molecular test for serial screening programs.

Related Information

###

Boilerplate

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.


Inquiries

Consumer:
888-INFO-FDA

The story behind COVID-19 vaccines – Science Magazine

Embedded Image

PHOTO: NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

Amid the staggering amount of suffering and death during this historic pandemic of COVID-19, a remarkable success story stands out. The development of several highly efficacious vaccines against a previously unknown viral pathogen, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in less than 1 year from the identification of the virus is unprecedented in the history of vaccinology. A frequently asked question is how such an extraordinary accomplishment could have been realized in such a short time frame, when timelines for other vaccines are measured in years if not decades. In fact, concern about this truncated timeline has contributed in part to the hesitancy in accepting these vaccines. What is not fully appreciated is that the starting point of the timeline for SARS-CoV-2 vaccines was not 10 January 2020, when the Chinese published the genetic sequence of the virus. Rather, it began decades earlier, out of the spotlight.

Two activities predate the successful COVID-19 vaccines: the utilization of highly adaptable vaccine platforms such as RNA (among others) and the adaptation of structural biology tools to design agents (immunogens) that powerfully stimulate the immune system. The RNA approach evolved over several years owing to the ingenuity of individual scientists, including Drew Weissman and Katalin Karikó, and the concentrated efforts of several biotech and pharmaceutical companies.

The discovery of an immunogen adaptable to the multiple platforms (messenger RNA and others) used for COVID-19 vaccines resulted from collaboration across different scientific subspecialities. At the Vaccine Research Center (VRC) of the U.S. National Institute of Allergy and Infectious Diseases, a group led by Peter Kwong had for several years used tools of structure-based vaccine design to determine the optimal structural conformation of a trimeric protein on the surface of the virus (the envelope protein) that allows HIV to bind to cells and ultimately trigger the production of antibodies that neutralize many HIV viral strains. Although this sophisticated approach has not yet led to a successful HIV vaccine, it caught the attention of another VRC investigator, Barney Graham, who was interested in generating a vaccine for respiratory syncytial virus (RSV). Graham joined Jason McLellan (of Kwong’s team) to adapt a structure-based approach to an RSV vaccine. They identified the prefusion conformation of the viral spike protein as highly immunogenic and created mutations to stabilize that conformation for successful use as an immunogen. This was a huge step toward the creation of a successful RSV vaccine.

VRC researchers and colleagues then built on the RSV advances. Graham’s team, including Kizzmekia Corbett, and collaborators in the laboratories of McLellan and Andrew Ward adopted this approach of mutational stabilization of prefusion proteins in their work on the spike protein of the coronaviruses that cause Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS). So, when the genetic sequence of the SARS-CoV-2 became available, Graham’s team lost no time in joining their long-time collaborators at Moderna to develop an RNA vaccine using a stabilized, prefusion spike protein as the immunogen. Pfizer and BioNTech, where Karikó was working, also used the RNA platform that she and Weissman had perfected and the immunogen designed by Graham to develop an RNA vaccine. Additional companies also used Graham’s immunogen in other vaccine platforms that had been evolving for years, to make SARS-CoV-2 vaccines.

SARS-CoV-2 vaccines based on the new immunogen rapidly moved to clinical trials. Several of these vaccines were tested in phase 3 efficacy trials at a time when the level of community spread of SARS-CoV-2 was extremely high, allowing vaccine efficacy endpoints of greater than 90% to be reached in a timely fashion. The speed and efficiency with which these highly efficacious vaccines were developed and their potential for saving millions of lives are due to an extraordinary multidisciplinary effort involving basic, preclinical, and clinical science that had been under way—out of the spotlight—for decades before the unfolding of the COVID-19 pandemic. When the stories and recounting of this pandemic are written, it is important that this history not be forgotten, as we are reminded once again of the societal value of a sustained and robust support of our scientific enterprise.

New Drugs To Treat COVID-19 Show Promise, Researchers Say : Shots – Health News – NPR

Deaths from COVID-19 are often due to the immune system overreacting to the coronavirus. New drugs to suppress that reaction are showing promise, say researchers. Westend61/Getty Images hide caption

toggle caption

Westend61/Getty Images

Deaths from COVID-19 are often due to the immune system overreacting to the coronavirus. New drugs to suppress that reaction are showing promise, say researchers.

Westend61/Getty Images

Researchers are reporting some progress in their search for drugs that tamp down the overwhelming immune reaction that can kill a patient with COVID-19.

These reactions are triggered by coronavirus infections and can veer out of control in some people. It’s this reaction, rather than the virus itself, that is the real peril for people seriously ill with COVID-19.

Doctors last year recognized that a cheap and readily available steroid drug called dexamethasone can often rein in this overreaction, which is a form of inflammation. In fact, it’s the only COVID-19 drug so far that clearly saves lives.

“Dexamethasone is a really powerful anti-inflammatory,” says Dr. Rajesh Gandhi, an infectious disease doctor at Harvard and Massachusetts General Hospital, but, “there are still people who need more.”

Two anti-inflammatory drugs that have been developed to treat rheumatoid arthritis are sometimes used, either instead of or in addition to the steroid.

Tocilizumab is recommended for patients who are getting rapidly worse in the intensive care unit. Another drug, baricitinib, is sometimes prescribed alongside an antiviral drug called remdesivir.

But there’s also a race to come up with something more.

Last week, Humanigen announced in a press release that its drug, lenzilumab, reduced the risk that someone with COVID-19 would need to be put on a ventilator.

“You really don’t want to be in the ICU. You don’t want to be on a ventilator,” says Dr. Cameron Durrant, president and CEO of Humanigen. “You don’t want to be in a hospital bed. So potentially offering something that gets patients out faster is something that we’re all striving for.”

Durrant says that based on a study of about 500 patients the company plans to ask the Food and Drug Administration to grant emergency authorization for its drug.

The press release certainly left an impression on investors, who at least briefly drove the company’s stock price sharply higher. That enthusiasm was tempered when scientists said the press release left some significant questions unanswered.

Derek Lowe is a pharmaceutical researcher who writes a related blog called In the Pipeline. He noted that there was a wide range of uncertainty about the reported results, which could mean that the experimental drug is either much worse or much better than the company reported.

Similar questions cropped up when the company NeuroRx announced in a press release that its drug, aviptadil, also showed promise in treating an excessive immune response in COVID-19.

Lenzilumab is in a class of medicines called monoclonal antibodies. They have been engineered to disable certain molecules that help regulate the immune system. The concept is that by interfering with the molecules that help orchestrate inflammation, it’s possible to mute the reaction. (The steroid dexamethasone, in contrast, is less targeted in its ability to tamp down an immune reaction.)

Another feature of these engineered antibodies: They are expensive to make, and companies often sell them for thousands of dollars a dose. So, Lowe doubts these drugs — even if the FDA authorizes them for emergency use — will replace cheap and readily available steroids as the first drug of choice.

“You would figure more expensive, more targeted sorts of inflammation drugs like this are going to be second or third line,” he says. “I think they’re going to help some, but they are not going to be game changers.”

Vaccines are the game changers, and as more and more people get vaccinated, fewer will end up in the hospital needing intensive care.

“It’s a paradox because these are the sort of expensive drugs, in many cases, that would be found in wealthy industrialized countries,” Lowe says. “But the wealthy industrialized countries are going to be the ones that have a higher percentage of people vaccinated with fewer patients who are even going to need them.”

One other challenge is these potential products are all rushing to market and haven’t been tested against one another, so it’s not clear which one might be better. Gandhi at Mass General says doctors also need to figure out the best way to combine them with other drugs, to treat COVID-19, and whether it’s safe to do so.

“Many of these anti-inflammatories suppress the immune system, so you want to make sure you don’t have extra side effects if you combine drugs,” he says.

In normal times, questions like these would be studied more slowly and methodically. But these aren’t normal times. The FDA is accepting a lower level of evidence for COVID-19 drugs. The key question is whether the benefits outweigh the risks. As a result, if these drugs get emergency authorization, there will still be a lot of lingering questions about them.

Gandhi says it’s important to remember that there are also drugs that can help keep people with COVID-19 out of the hospital in the first place. These are monoclonal antibodies that are customized to target and neutralize the coronavirus. They are available nationwide for people at elevated risk for hospitalization with COVID-19 and are available through a government program at no cost. But they are not used as widely as they could be.

You can contact NPR science correspondent at rharris@npr.org.

Coronavirus (COVID-19) Update: April 6, 2021 – FDA.gov

For Immediate Release:

The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:

  • The FDA issued an Emergency Use Authorization (EUA) to Symbiotica, Inc., for the COVID-19 Self-Collected Antibody Test System, making it the first serology test authorized for use with a blood sample self-collected at-home. The Symbiotica COVID-19 Self-Collected Antibody Test System requires a prescription from a health care provider. The test system is intended to aid in identifying if a person has had an adaptive immune response to SARS-CoV-2, indicating that the person may have had a recent or previous COVID-19 infection. Samples collected at home are sent to a Symbiotica, Inc. laboratory for analysis.
  • On April 5, 2021, the FDA issued and immediately implemented a new guidance: Development of Abbreviated New Drug Applications During the COVID-19 Pandemic – Questions and Answers. The guidance provides general recommendations to prospective generic drug applicants related to generic drug product development and regulatory submissions in the form of questions and answers that have been received and addressed by the FDA during the COVID-19 public health emergency. The FDA is issuing this guidance so that the development of generic drugs and submission of applications can continue during the COVID-19 public health emergency, ultimately helping to ensure that Americans continue to have access to safe, effective generic drugs.
  • Testing updates:
    • As of today, 355 tests and sample collection devices are authorized by the FDA under emergency use authorizations (EUAs). These include 258 molecular tests and sample collection devices, 75 antibody and other immune response tests, and 22 antigen tests. There are 43 molecular authorizations and 1 antibody authorization that can be used with home-collected samples. There is one molecular prescription at-home test, two antigen prescription at-home test, four over-the-counter (OTC) at-home antigen test, and one OTC molecular test.
    • The FDA has authorized 6 antigen tests and 1 molecular test for serial screening programs.

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

###


Inquiries

Consumer:
888-INFO-FDA


Related Information

Free COVID-19 Testing Events Added in Eight Counties – West Virginia Department of Health and Human Resources

The West Virginia Department of Health and
Human Resources (
DHHR) announced additional
free COVID-19 testing events in eight counties.

“As these counties are experiencing increases in
COVID-19 cases right now, we encourage all residents to take advantage of these
free testing events,” said Dr. Ayne Amjad, State Health Officer and
Commissioner of DHHR’s Bureau for Public Health. “Testing is vital if you are
experiencing symptoms such as cough, sore throat, runny nose, fatigue or body
aches, or have been exposed to someone with COVID-19.”

Pop-up events will be held April 5-10, 2021, in Berkeley, Boone, Fayette,
Hardy, Jefferson, Morgan, Putnam, and Raleigh counties:

Berkeley
County

  • April 5-9, 10:00 AM – 6:00 PM, 891 Auto Parts Place, Martinsburg,
    WV.

  • April 5-9, 10:00 AM – 6:00 PM, Ambrose Park, 25404 Mall
    Drive, Martinsburg, WV.

  • April 6 and 8, 1:00 PM – 5:00 PM, Shenandoah Community Health,
    99 Tavern Road, Martinsburg, WV.

  • April 6 and 8, 4:30 PM – 8:00 PM, Dorothy McCormack Building,
    2000 Foundation Way, Martinsburg, WV.

 

In addition, pharmacy sites offer recurring testing every week in
Berkeley County:

  • Reeds Pharmacy, 5078 Williamsport Pike, Martinsburg, WV; Monday –
    Friday, 9:00 AM – 7:00 PM; Saturday 9:00 AM – 2:00 PM.

  • WVU Medicine Berkeley Medical Center, 2500 Hospital Drive, Martinsburg,
    WV; Tuesday, Thursday, 4:30 PM – 8:00 PM.

  • Woman and Child Inc., 1178 Shepherdstown Road, Martinsburg, WV,
    Wednesday, 9:00 AM – 3:00 PM; Friday 9:00 AM – 12:00 PM. Call 304-264-9332 for
    an appointment.

  • Walgreens, 7916 Winchester Avenue, Inwood, WV; Monday – Saturday, 8:00
    AM – 9:00 PM; Sunday 10:00 AM – 6:00 PM.

 

Boone County

  • April 6-8, 10:00 AM – 3:00 PM, Boone County Health
    Department, 213 Kenmore Drive, Danville, WV. Pre-register at
    https://wv.getmycovidresult.com/

  • April 9, 12:00 PM – 6:00 PM, Boone County Health
    Department, 213 Kenmore Drive, Danville, WV.  

 

In addition, pharmacy sites offer recurring testing every week in
Boone County:

  • Hygeia, 37456 Coal River Road, Whitesville, WV; Monday – Friday,
    8:30 AM – 5:00 PM.

  • Hygeia, 35767 Pond Fork Road, Wharton, WV; Monday – Friday, 8:30
    AM – 5:00 PM.

  • Southern West Virginia Health Systems, 471 Main Street, Madison, WV;
    Wednesday
    9:00 AM – 3:00 PM.

  • Walgreens, 69 Lewis Street, Whitesville, WV; Monday – Friday, 9:00 AM –
    8:00 PM; Saturday 9:00 AM – 6:00 PM; Sunday 10:00 AM – 6:00 PM. For an
    appointment, visit
    https://www.walgreens.com/findcare/covid19/testing.

 

Fayette County

  • April 7, 10:00 AM – 2:00 PM, J.W. &
    Hazel
    Ruby West
    Virginia Welcome Center, 55 Hazel Lane, Mount Hope, WV.  

  • April 8, 3:00 PM – 6:00 PM, J.W. &
    Hazel
    Ruby West
    Virginia Welcome Center, 55 Hazel Lane, Mount Hope, WV.  

  • April 9, 10:00 AM – 2:00 PM, Smithers Gateway Center, 1
    Greyhound Lane, Smithers, WV.

 

In addition, pharmacy sites offer recurring testing every week in
Fayette County:

  • Fayette County Health Department, 202 Church Street, Fayetteville,
    WV; Monday and Wednesday, 9:00 AM – 11:00 AM. For an appointment, call
    304-574-1617.

  • Walgreens, 1201 Main Street, Oak Hill, WV; Monday – Friday, 9:00
    AM – 8:00 PM; Saturday 9:00 AM – 6:00 PM; Sunday 10:00 AM – 6:00 PM. For an
    appointment, visit
    https://www.walgreens.com/findcare/covid19/testing.

 

Hardy County

 

In addition, pharmacy sites offer recurring testing every week in
Hardy County:

  • Love Memorial Clinic, 112 Kuykendall Lane, Moorefield, WV; Monday
    – Friday, 9:00 AM – 6:00 PM; Saturday, 9:00 AM – 11:00 PM. For an appointment,
    call 304-530-7755.

  • South Fork Pharmacy, 732 N. Main Street, Moorefield, WV; Monday –
    Friday 9:30 AM –12:30 PM. To schedule an appointment, visit
    https://hipaa.jotform.com/210342593690152 or call
    304-530-1044.

 

Jefferson
County

  • April 5-9, 10:00 AM – 6:00 PM, Hollywood Casino, 750
    Hollywood Drive, Charles Town, WV.

  • April 5-9, 10:00 AM – 6:00 PM, Shepherd University
    Wellness Center Parking Lot, 164 University Drive, Shepherdstown, WV.

  • April 10, 10:00 AM – 2:00 PM, Hollywood Casino, 750
    Hollywood Drive, Charles Town, WV.

  • April 10, 10:00 AM – 2:00 PM, Shepherd
    University Wellness Center Parking Lot, 164 University Drive, Shepherdstown, WV.

 

In addition, pharmacy sites offer recurring testing every week in
Jefferson County:

 

Morgan County

  • April 5-9, 10:00 AM – 6:00 PM, Valley Health War Memorial
    Hospital, 1 Health Way, Berkeley Springs, WV.  

 

In addition, pharmacy sites offer recurring testing every week in
Morgan County:

  • Reeds Pharmacy, 261 Berkmore Place,
    Berkeley Springs, WV; Monday – Friday, 9:00 AM – 7:00 PM; Saturday and Sunday 9:00
    AM – 2:00 PM.

 

Putnam County

  • April 6 and 10, 9:00 AM – 1:00 PM, Liberty Square, 613 Putnam
    Village, Hurricane, WV. Pre-register at
    bit.ly/pchd-covid.

  • April 7 and 9, 9:00 AM – 4:00 PM, Liberty Square, 613 Putnam
    Village, Hurricane, WV. Pre-register at
    bit.ly/pchd-covid.

  • April 8, 9:00 AM – 7:00 PM, Liberty Square, 613 Putnam
    Village, Hurricane, WV. Pre-register at
    bit.ly/pchd-covid.

 

In addition, pharmacy sites offer recurring testing every week in
Putnam County:

  • FamilyCare Health Centers, 503 Roosevelt
    Boulevard, Eleanor, WV; Monday – Thursday, 2:00 PM – 4:00 PM.

  • FamilyCare Health Centers, 97 Great Teays
    Boulevard, Scott Depot, WV; Monday – Thursday, 2:00 PM – 4:00 PM.

  • Fruth, 501 Roosevelt Boulevard, Eleanor,
    WV; Monday, Wednesday, Thursday, and Friday, 9:00 AM – 6:00 PM; Saturday, 9:00
    AM – 4:00 PM; Sunday, 11:00 AM – 3:00 PM. To schedule an appointment, visit
    https://www.doineedacovid19test.com/Eleanor_WV_2045.html.

  • Fruth, 3109 Teays Valley Road, Hurricane,
    WV; Monday, Wednesday, Thursday, Friday, and Saturday; 9:00 AM – 8:00 PM; Sunday,
    11:00 AM – 5:00 PM. To schedule an appointment, visit
     https://www.doineedacovid19test.com/Hurricane_WV_1547.html.

  • Fruth, 4539 Teays Valley Road, Scott
    Depot, WV; Monday, Wednesday, Thursday, Friday, and Saturday, 9:00 AM – 7:00 PM;
    Sunday, 12:00 PM – 5:00 PM. To schedule an appointment, visit
    https://www.doineedacovid19test.com/ScottDepot_WV_1544.html.

  • Fruth, 12803 Winfield Road, Winfield, WV;
    Monday, Wednesday, Thursday, and Friday, 9:00 AM – 6:00 PM; Saturday, 9:00 AM –
    4:00 PM; Sunday, 11:00 AM – 3:00 PM. To schedule an appointment, visit
    https://www.doineedacovid19test.com/Winfield_WV_2041.html.

  • Walgreens, 201 Roosevelt Boulevard,
    Eleanor, WV; Monday – Friday, 9:00 AM – 8:00 PM; Saturday, 9:00 AM – 6:00 PM;
    Sunday, 10:00 AM – 6:00 PM. To schedule an appointment, visit
    https://www.walgreens.com/findcare/covid19/testing.

  • Walgreens, 3000 Teays Valley Road, WV; Monday
    – Friday, 9:00 AM – 9:00 PM; Saturday, 9:00 AM – 6:00 PM; Sunday, 10:00 AM – 6:00
    PM. To schedule an appointment, visit
    https://www.walgreens.com/findcare/covid19/testing.

  • Walgreens, 215 State Route 34, Hurricane,
    WV; Monday – Friday, 9:00 AM – 9:00 PM; Saturday, 9:00 AM – 6:00 PM; Sunday, 10:00
    AM – 6:00 PM. To schedule an appointment, visit
    https://www.walgreens.com/findcare/covid19/testing.

 

Raleigh County

  • April 5, 11:00 AM – 3:00 PM, Beckley-Raleigh County
    Health Department, 1602 Harper Road, Beckley, WV. Pre-register at
    https://wv.getmycovidresult.com/.

  • April 6, 10:00 AM – 2:00 PM, FMRS Health Systems, 102
    South Eisenhower Drive, Beckley, WV.

  • April 6, 2:15 PM – 4:00 PM, FMRS Health Systems, 216
    South Vance Drive, Beckley, WV.

  • April 6, 3:00 PM – 6:00 PM, Beckley-Raleigh County
    Health Department, 1602 Harper Road, Beckley, WV. Pre-register at
    https://wv.getmycovidresult.com/.

  • April 7-8, 10:00 AM – 2:00 PM, Beckley-Raleigh County
    Health Department, 1602 Harper Road, Beckley WV. Pre-register at
    https://wv.getmycovidresult.com/.


In addition, pharmacy sites offer recurring testing every week in Raleigh
County:

  • Beckley Appalachian Regional Healthcare, 306
    Stanaford Road, Beckley, WV; Monday – Friday, 10:00 AM – 2:00 PM.

  • Beckley Health Right, 111 Randolph
    Street, Beckley, WV; Monday – Friday, 9:00 AM – 3:00 PM.

  • Walgreens, 886 Ritter Drive, Beaver, WV; Monday
    – Friday, 9:00 AM – 8:00 PM; Saturday, 9:00 AM – 6:00 PM; Sunday, 10:00 AM – 6:00
    PM. To schedule an appointment, visit
    https://www.walgreens.com/findcare/covid19/testing.

 

Free COVID-19 testing is
available to all West Virginia residents, including asymptomatic individuals. For daily COVID-19 testing
events, as well as additional periodic and pharmacy testing events, visit
https://dhhr.wv.gov/COVID-19/pages/testing.aspx.

Additionally,
West Virginians may pre-register for their COVID-19 vaccination at
vaccinate.wv.gov or locate a vaccine at www.vaccinefinder.org.

COVID-19 Daily Update 4-4-2021 – West Virginia Department of Health and Human Resources

​The West Virginia Department of Health and Human Resources (DHHR) reports as of April 4, 2021, there have been 2,488,126 total confirmatory laboratory results received for COVID-19, with 143,456 total cases and 2,695 total deaths.

DHHR has confirmed the deaths of a 77-year old male from Ohio County and a 50-year old male from Wetzel County.

“Spring is a time of hope and new beginnings,” said Bill J. Crouch, DHHR Cabinet Secretary. “In our sadness today, we must not lose sight of the ability to move beyond the pandemic by prioritizing safety measures and vaccination.”

CASES PER COUNTY: Barbour (1,322), Berkeley (10,910), Boone (1,779), Braxton (842), Brooke (2,073), Cabell (8,450), Calhoun (252), Clay (413), Doddridge (517), Fayette (3,087), Gilmer (731), Grant (1,188), Greenbrier (2,536), Hampshire (1,640), Hancock (2,643), Hardy (1,399), Harrison (5,212), Jackson (1,813), Jefferson (4,120), Kanawha (13,352), Lewis (1,113), Lincoln (1,367), Logan (2,953), Marion (3,976), Marshall (3,191), Mason (1,887), McDowell (1,427), Mercer (4,419), Mineral (2,670), Mingo (2,326), Monongalia (8,709), Monroe (1,027), Morgan (1,040), Nicholas (1,401), Ohio (3,893), Pendleton (670), Pleasants (820), Pocahontas (621), Preston (2,738), Putnam (4,622), Raleigh (5,687), Randolph (2,468), Ritchie (644), Roane (545), Summers (734), Taylor (1,159), Tucker (519), Tyler (658), Upshur (1,796), Wayne (2,769), Webster (450), Wetzel (1,189), Wirt (370), Wood (7,475), Wyoming (1,843).

Delays may be experienced with the reporting of information from the local health department to DHHR. As case surveillance continues at the local health department level, it may reveal that those tested in a certain county may not be a resident of that county, or even the state as an individual in question may have crossed the state border to be tested. Such is the case of Pendleton County in this report.

West Virginians may pre-register for their COVID-19 vaccination at vaccinate.wv.gov. The COVID-19 dashboard located at www.coronavirus.wv.gov shows the total number of vaccines administered. Please see the vaccine summary tab for more detailed information.

Free COVID-19 testing is available to all West Virginia residents. For daily testing events, as well as additional periodic and pharmacy testing events, visit https://dhhr.wv.gov/COVID-19/pages/testing.aspx. 

Coronavirus (COVID-19) Update: April 2, 2021 – FDA.gov

For Immediate Release:

The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:

  • Following recent FDA actions to support test development, the FDA took swift action this week to get more tests for screening asymptomatic individuals on the market. On March 31, the FDA authorized several COVID-19 tests for over-the-counter (OTC) use without a prescription when used for serial screening (testing asymptomatic individuals multiple times on a routine basis), such as testing twice a week in schools or other settings. The FDA also authorized serial screening tests for use in a point-of-care (POC) setting, such as a doctor’s office. These authorizations follow the FDA’s recent actions to advance OTC and other screening test development. These tests:
    • Can be used to test people with or without COVID-19 symptoms.
    • Are antigen tests that detect proteins from SARS-CoV-2, the virus that causes COVID-19, from a nasal swab sample.
    • Give results in 10-30 minutes without needing to send a sample to a laboratory for analysis.
  • This week, the FDA posted a new web page SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests for clinical laboratory staff and health care providers about the impact of viral mutations on COVID-19 molecular, antigen, and serology tests. This web page builds on the letter the FDA issued January 8, 2021, alerting clinical laboratory staff and health care providers to the potential for false negative results due to the impact of viral mutations on molecular SARS-CoV-2 tests. The web page includes specific molecular tests impacted by viral mutations and recommendations for those tests, including, new information on Cepheid Xpert Xpress SARS-CoV-2, Xpert Xpress SARS-CoV-2 DoD, and Xpert Omni SARS-CoV-2 tests. The FDA will update this page as significant new information about viral mutations and impact on COVID-19 tests becomes available. The FDA will announce any updates by email to CDRH In Vitro Diagnostics email list subscribers and in COVID-19 Update press releases.
  • Today, the FDA posted translations of the Consumer Update: Learn More about COVID-19 Vaccines From the FDA in five additional languages: Chinese, Korean, Spanish, Tagalog, and Vietnamese.
  • As part of the FDA’s effort to protect consumers, the agency issued a warning letter jointly with the Federal Trade Commission to Natural Adventure, LLC for selling unapproved products with fraudulent COVID-19 claims. The company sells “Purity Sanitizer with 70% Alcohol” and “Purity Essential Oil Blend” and misleadingly represents that the products can mitigate, prevent, treat, diagnose or cure COVID-19 in people. The FDA requested that Natural Adventure, LLC take immediate action to cease the sale of any unapproved and unauthorized products for the treatment or prevention of COVID-19. Consumers concerned about COVID-19 should consult with their health care provider.
  • Testing updates:

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

###


Inquiries

Consumer:
888-INFO-FDA


Related Information

FDA.gov Coronavirus (COVID-19) Update: April 2, 2021 – FDA.gov

For Immediate Release:

The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:

  • Following recent FDA actions to support test development, the FDA took swift action this week to get more tests for screening asymptomatic individuals on the market. On March 31, the FDA authorized several COVID-19 tests for over-the-counter (OTC) use without a prescription when used for serial screening (testing asymptomatic individuals multiple times on a routine basis), such as testing twice a week in schools or other settings. The FDA also authorized serial screening tests for use in a point-of-care (POC) setting, such as a doctor’s office. These authorizations follow the FDA’s recent actions to advance OTC and other screening test development. These tests:
    • Can be used to test people with or without COVID-19 symptoms.
    • Are antigen tests that detect proteins from SARS-CoV-2, the virus that causes COVID-19, from a nasal swab sample.
    • Give results in 10-30 minutes without needing to send a sample to a laboratory for analysis.
  • This week, the FDA posted a new web page SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests for clinical laboratory staff and health care providers about the impact of viral mutations on COVID-19 molecular, antigen, and serology tests. This web page builds on the letter the FDA issued January 8, 2021, alerting clinical laboratory staff and health care providers to the potential for false negative results due to the impact of viral mutations on molecular SARS-CoV-2 tests. The web page includes specific molecular tests impacted by viral mutations and recommendations for those tests, including, new information on Cepheid Xpert Xpress SARS-CoV-2, Xpert Xpress SARS-CoV-2 DoD, and Xpert Omni SARS-CoV-2 tests. The FDA will update this page as significant new information about viral mutations and impact on COVID-19 tests becomes available. The FDA will announce any updates by email to CDRH In Vitro Diagnostics email list subscribers and in COVID-19 Update press releases.
  • Today, the FDA posted translations of the Consumer Update: Learn More about COVID-19 Vaccines From the FDA in five additional languages: Chinese, Korean, Spanish, Tagalog, and Vietnamese.
  • As part of the FDA’s effort to protect consumers, the agency issued a warning letter jointly with the Federal Trade Commission to Natural Adventure, LLC for selling unapproved products with fraudulent COVID-19 claims. The company sells “Purity Sanitizer with 70% Alcohol” and “Purity Essential Oil Blend” and misleadingly represents that the products can mitigate, prevent, treat, diagnose or cure COVID-19 in people. The FDA requested that Natural Adventure, LLC take immediate action to cease the sale of any unapproved and unauthorized products for the treatment or prevention of COVID-19. Consumers concerned about COVID-19 should consult with their health care provider.
  • Testing updates:

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

###


Inquiries

Consumer:
888-INFO-FDA


Related Information